tcf-no-longer-accepting-cases

July 24, 2018 — Bayer will stop all sales of Essure implants at the end of the year, making the U.S. the last country where the controversial device was still sold.

Bayer stands by the safety and effectiveness of Essure, and claims that pulling it off the market in the U.S. was a “business decision” based on a 40% drop in sales.

Bayer stopped selling Essure in all countries except the U.S. last year, after several international health agencies issued safety warnings.

In the U.S., over 16,000 lawsuits have been filed by women who were injured by Essure. Thousands of women have reported severe side effects, or complained that they were not warned of the potential risks.

The FDA approved Essure in 2002 as the only non-surgical sterilization device on the market. The agency refused to recall Essure and consistently claimed that the benefits outweighed the risks.

Even so, the FDA added a “Black Box” warning to the label of Essure and took the unusual step of drafting a 3-page checklist outlining the potential risks. In April, the FDA limited sales of Essure to doctors who agreed to go over the checklist with patients before implanting Essure.

The potential side effects include changes in menstrual bleeding, pregnancy, permanent pain, perforation and migration of the device, allergic or hypersensitivity reactions, or immune-type reactions. If complications occur, surgery to remove Essure is often necessary.

 

Meet Your Attorney

Collen A. Clark

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

“Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

To contact Collen, please fill out the contact form below:

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 879-3040.
  • This field is for validation purposes and should be left unchanged.